Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide Product Information
Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Ezetimibe. The product is supplied by Clearsynth under CAT No. CS-O-10372.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide
CAS No.
1426174-41-5
CAT No.
CS-O-10372
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C30H25D4F2NO9
Molecular Weight
589.57
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Ezetimibe.
Overview
"Phase-II labelled metabolite of Ezetimibe, an antihyperlipoproteinemic. A cholesterol absorption inhibitor."
Synonyms
Ezetimibe N-Phenyl-d4 Phenoxy Glucuronide
Application Notes
"Phase-II labelled metabolite of Ezetimibe, an antihyperlipoproteinemic. A cholesterol absorption inhibitor."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.